Poor Positioning Responsible for Most Mammogram Deficiencies
By MedImaging International staff writers Posted on 26 May 2016 |
Image: A woman undergoing a mammogram (Photo courtesy of the FDA).
A new report by the U.S. Food and Drug Administration (FDA, Silver Spring, MD, USA) suggests that proper patient positioning remains one of the most important aspects of high-quality mammography imaging.
The FDA report notes that patient positioning according to guidelines set out in the Mammography Quality Standards Act (MQSA) is important, because only those portions of the breast, which are included on the mammographic image, can be evaluated for signs of cancer. Any portion of the breast not imaged cannot be evaluated, and cancers in those portions of the breast can be missed. The report cites a study from 2002 that found that the sensitivity of mammography dropped from 84.4% among cases with passing positioning to 66.3% among cases with failed positioning.
The report also clarified that although the technologist performs the mammogram, the responsibility for correct positioning is shared by the technologist and the interpreting physician, and emphasizes that the physicians are the final arbiters of the quality of mammography images, and that they should communicate their satisfaction or dissatisfaction with the quality of the images. According to the FDA, this is the crucial first step in the identification of problems and the initiation of corrective actions.
Technologists should also be trained in proper positioning, and should seek feedback from fellow technologists and interpreting physicians. Since the consequences of poor positioning can be very significant not just for individual patients, but for mammography facilities as well, affecting their MQSA accreditation, the physicians should in turn review the elements of proper patient positioning, and give constructive feedback to technologists on the mammograms that are presented to them for interpretation.
The MQSA, passed in 1999, is the primary mechanism for enforcing compliance with quality standards for mammography facilities. The FDA reports that as of May 1, 2016, there were a total of 8,738 certified facilities in the United States sporting a total of 16,042 accredited units. Of those certified facilities, 8,493 had full field digital mammography (FFDM) units.
Related Links:
U.S. Food and Drug Administration
The FDA report notes that patient positioning according to guidelines set out in the Mammography Quality Standards Act (MQSA) is important, because only those portions of the breast, which are included on the mammographic image, can be evaluated for signs of cancer. Any portion of the breast not imaged cannot be evaluated, and cancers in those portions of the breast can be missed. The report cites a study from 2002 that found that the sensitivity of mammography dropped from 84.4% among cases with passing positioning to 66.3% among cases with failed positioning.
The report also clarified that although the technologist performs the mammogram, the responsibility for correct positioning is shared by the technologist and the interpreting physician, and emphasizes that the physicians are the final arbiters of the quality of mammography images, and that they should communicate their satisfaction or dissatisfaction with the quality of the images. According to the FDA, this is the crucial first step in the identification of problems and the initiation of corrective actions.
Technologists should also be trained in proper positioning, and should seek feedback from fellow technologists and interpreting physicians. Since the consequences of poor positioning can be very significant not just for individual patients, but for mammography facilities as well, affecting their MQSA accreditation, the physicians should in turn review the elements of proper patient positioning, and give constructive feedback to technologists on the mammograms that are presented to them for interpretation.
The MQSA, passed in 1999, is the primary mechanism for enforcing compliance with quality standards for mammography facilities. The FDA reports that as of May 1, 2016, there were a total of 8,738 certified facilities in the United States sporting a total of 16,042 accredited units. Of those certified facilities, 8,493 had full field digital mammography (FFDM) units.
Related Links:
U.S. Food and Drug Administration
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection